- Home
- URG vs NVCT Comparison
URG vs NVCT Comparison
Compare URG & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URG
- NVCT
- Stock Information
- Founded
- URG 2004
- NVCT 2020
- Country
- URG United States
- NVCT United States
- Employees
- URG N/A
- NVCT N/A
- Industry
- URG Precious Metals
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- URG Basic Materials
- NVCT Health Care
- Exchange
- URG Nasdaq
- NVCT Nasdaq
- Market Cap
- URG 280.5M
- NVCT 249.1M
- IPO Year
- URG N/A
- NVCT 2022
- Fundamental
- Price
- URG $0.71
- NVCT $8.99
- Analyst Decision
- URG Strong Buy
- NVCT Strong Buy
- Analyst Count
- URG 2
- NVCT 3
- Target Price
- URG $2.45
- NVCT $17.00
- AVG Volume (30 Days)
- URG 3.2M
- NVCT 157.3K
- Earning Date
- URG 05-08-2025
- NVCT 05-06-2025
- Dividend Yield
- URG N/A
- NVCT N/A
- EPS Growth
- URG N/A
- NVCT N/A
- EPS
- URG N/A
- NVCT N/A
- Revenue
- URG $33,706,000.00
- NVCT N/A
- Revenue This Year
- URG N/A
- NVCT N/A
- Revenue Next Year
- URG $251.38
- NVCT N/A
- P/E Ratio
- URG N/A
- NVCT N/A
- Revenue Growth
- URG 200.09
- NVCT N/A
- 52 Week Low
- URG $0.55
- NVCT $4.44
- 52 Week High
- URG $1.88
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- URG 47.77
- NVCT 47.46
- Support Level
- URG $0.67
- NVCT $8.01
- Resistance Level
- URG $0.80
- NVCT $9.62
- Average True Range (ATR)
- URG 0.04
- NVCT 1.04
- MACD
- URG 0.00
- NVCT -0.16
- Stochastic Oscillator
- URG 32.85
- NVCT 27.96
About URG Ur Energy Inc (Canada)
Ur-Energy Inc is y is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.